89 related articles for article (PubMed ID: 11051641)
1. New drugs fight TB.
AIDS Patient Care STDS; 2000 Sep; 14(9):522. PubMed ID: 11051641
[No Abstract] [Full Text] [Related]
2. Preclinical testing of new drugs for tuberculosis: current challenges.
Lenaerts AJ; Degroote MA; Orme IM
Trends Microbiol; 2008 Feb; 16(2):48-54. PubMed ID: 18182291
[TBL] [Abstract][Full Text] [Related]
3. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Kwon YS; Kim YH; Suh GY; Chung MP; Kim H; Kwon OJ; Choi YS; Kim K; Kim J; Shim YM; Koh WJ
Clin Infect Dis; 2008 Aug; 47(4):496-502. PubMed ID: 18611154
[TBL] [Abstract][Full Text] [Related]
4. The "source" of drug-resistant TB outbreaks.
van Helden PD; Victor T; Warren RM
Science; 2006 Oct; 314(5798):419-20. PubMed ID: 17053131
[No Abstract] [Full Text] [Related]
5. Multidrug-resistant tuberculosis (TB) resistant to fluoroquinolones and streptomycin but susceptible to second-line injection therapy has a better prognosis than extensively drug-resistant TB.
Chan ED; Strand MJ; Iseman MD
Clin Infect Dis; 2009 Mar; 48(5):e50-2. PubMed ID: 19191632
[TBL] [Abstract][Full Text] [Related]
6. Trench warfare in a battle with TB.
Marshall E
Science; 2008 Jul; 321(5887):362-4. PubMed ID: 18635790
[No Abstract] [Full Text] [Related]
7. Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis.
Kim HR; Hwang SS; Kim HJ; Lee SM; Yoo CG; Kim YW; Han SK; Shim YS; Yim JJ
Clin Infect Dis; 2007 Nov; 45(10):1290-5. PubMed ID: 17968823
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
9. New treatments for new TB strains.
Brennan PJ; MacGregor RR
Pa Med; 1996 Jul; 99(7):26-7. PubMed ID: 8755785
[TBL] [Abstract][Full Text] [Related]
10. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
[TBL] [Abstract][Full Text] [Related]
11. [Drug-resistant tuberculosis: resistance mechanisms and drug susceptibility of Mycobacterium tuberculosis].
Katalinić-Janković V; Obrovac M
Acta Med Croatica; 2004; 58(4):323-8. PubMed ID: 15700689
[TBL] [Abstract][Full Text] [Related]
12. Should tuberculosis programmes invest in second-line treatments for multidrug-resistant tuberculosis (MDR-TB)?
Coker R
Int J Tuberc Lung Dis; 2002 Aug; 6(8):649-50. PubMed ID: 12150473
[No Abstract] [Full Text] [Related]
13. Extensively drug-resistant tuberculosis: new strains, new challenges.
Banerjee R; Schecter GF; Flood J; Porco TC
Expert Rev Anti Infect Ther; 2008 Oct; 6(5):713-24. PubMed ID: 18847407
[TBL] [Abstract][Full Text] [Related]
14. Developing new drugs for the treatment of drug-resistant tuberculosis: a regulatory perspective.
Sacks LV; Behrman RE
Tuberculosis (Edinb); 2008 Aug; 88 Suppl 1():S93-100. PubMed ID: 18762157
[TBL] [Abstract][Full Text] [Related]
15. Acquisition of drug resistance in multidrug-resistant Mycobacterium tuberculosis during directly observed empiric retreatment with standardized regimens.
Han LL; Sloutsky A; Canales R; Naroditskaya V; Shin SS; Seung KJ; Timperi R; Becerra MC
Int J Tuberc Lung Dis; 2005 Jul; 9(7):818-21. PubMed ID: 16013781
[TBL] [Abstract][Full Text] [Related]
16. Shortening the treatment of tuberculosis.
Mitchison DA
Nat Biotechnol; 2005 Feb; 23(2):187-8. PubMed ID: 15696148
[No Abstract] [Full Text] [Related]
17. [Reasons for drug-resistant tuberculosis emergence].
Tu DH
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):403-5. PubMed ID: 17673006
[No Abstract] [Full Text] [Related]
18. [Treatment outcomes of multidrug-resistant tuberculosis--comparison between success and failure cases].
Shigetoh E; Murakami I; Yokosaki Y; Kurimoto N
Kekkaku; 2001 Dec; 76(12):723-8. PubMed ID: 11806128
[TBL] [Abstract][Full Text] [Related]
19. Treatment of multiple drug-resistant tuberculosis (MDR-TB) in Iran.
Mirsaeidi SM; Tabarsi P; Khoshnood K; Pooramiri MV; Rowhani-Rahbar A; Mansoori SD; Masjedi H; Zahirifard S; Mohammadi F; Farnia P; Masjedi MR; Velayati AA
Int J Infect Dis; 2005 Nov; 9(6):317-22. PubMed ID: 16183321
[TBL] [Abstract][Full Text] [Related]
20. [Spread of multidrug resistance of Mycobacterium and its impact on the efficiency of treatment in patients with tuberculosis in the penitentiaries of the Arkhangelsk Region].
Mar'iandyshev AO; Nizovtseva NI; Glomozda PG; Panasik VP; Duginova TN; Kuznetsov AA
Probl Tuberk Bolezn Legk; 2005; (5):19-21. PubMed ID: 15988972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
